Bretz, Frank.
Bretz, Frank, 1971-
Frank Bretz researcher
VIAF ID: 51420499 (Personal)
Permalink: http://viaf.org/viaf/51420499
Preferred Forms
-
-
100 1 _ ‡a Bretz, Frank
-
100 1 _ ‡a Bretz, Frank
-
-
-
-
-
100 1 _ ‡a Bretz, Frank ‡d 1971-
-
100 1 _ ‡a Bretz, Frank ‡d 1971-
-
-
-
100 0 _ ‡a Frank Bretz ‡c researcher
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Adaptive designs based on the truncated product method |
![]() |
Adaptive designs: The Swiss Army knife among clinical trial designs? |
![]() |
Advanced multiplicity adjustment methods in clinical trials |
![]() |
Alterations of pre-mRNA splicing in human inflammatory bowel disease |
![]() |
Assessing the similarity of dose response and target doses in 2 non-overlapping subgroups. |
![]() ![]() |
Author's reply: To PMID 21837623. |
![]() |
Authors' response to comments |
![]() |
Bayesian predictive power for interim adaptation in seamless phase II/III trials where the endpoint is survival up to some specified timepoint. |
![]() |
Berechnung der multivariaten Normal- und t-Verteilung |
![]() |
Commentary on Parker and Weir |
![]() |
Comparing a stratified treatment strategy with the standard treatment in randomized clinical trials |
![]() |
Compatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni-based closed tests |
![]() |
Computation of multivariate normal and t probabilities |
![]() ![]() ![]() ![]() ![]() |
Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology |
![]() |
Correction |
![]() |
Design and analysis of dose-finding studies combining multiple comparisons and modeling procedures. |
![]() |
Designing dose finding studies with an active control for exponential families |
![]() ![]() |
Dose finding - a challenge in statistics |
![]() |
Equivalence of regression curves sharing common parameters |
![]() |
Equivalence tests for binary efficacy-toxicity responses |
![]() |
Estimands: discussion points from the PSI estimands and sensitivity expert group |
![]() |
Estimands in clinical trials - broadening the perspective. |
![]() |
Experimental designs for small randomised clinical trials: an algorithm for choice |
![]() |
Flexible alpha allocation strategies for confirmatory adaptive enrichment clinical trials with a prespecified subgroup |
![]() |
Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests |
![]() |
Hierarchical testing of multiple endpoints in group-sequential trials. |
![]() |
Identifying effective and/or safe doses by stepwise confidence intervals for ratios |
![]() |
Innovative Approaches for Designing and Analyzing Adaptive Dose-Ranging Trials |
![]() |
Joint EMA, ISBS, and DR-IBS International Symposium on Biopharmaceutical Statistics: bridging drug development from research to marketing. |
![]() |
MCP2009 - 6 |
![]() |
Memory and other properties of multiple test procedures generated by entangled graphs. |
![]() |
Model-based dose finding under model uncertainty using general parametric models |
![]() |
Model identification for dose response signal detection |
![]() ![]() |
Model selection versus model averaging in dose finding studies |
![]() |
Multiple confidence intervals for selected parameters adjusted for the false coverage rate in monotone dose-response microarray experiments. |
![]() |
Multiple hypotheses testing based on ordered p values--a historical survey with applications to medical research |
![]() |
Multiple testing problems in pharmaceutical statistics |
![]() ![]() |
Multiplicity and replicability: two sides of the same coin |
![]() |
Multiplicity in confirmatory clinical trials: a case study with discussion from a JSM panel |
![]() |
Normal probability plots with confidence. |
![]() |
A note on testing families of hypotheses using graphical procedures. |
![]() |
On the efficiency of two-stage response-adaptive designs |
![]() |
Planung und Auswertung von Dosis-Wirkungs-Studien unter Verwendung von multiplen Testprozeduren |
![]() |
Power and sample size computations in simultaneous tests for non-inferiority based on relative margins. |
![]() |
Power and sample size when multiple endpoints are considered |
![]() |
Powerful modifications of Williams' test on trend |
![]() |
Practical considerations for optimal designs in clinical dose finding studies |
![]() |
Quantitative approaches underpinning decision making |
![]() |
Recent developments in multiple comparison procedures, c2004: |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Rejoinder |
![]() |
Rejoinder to discussions on “Optimal test procedures for multiple hypotheses controlling the familywise expected loss” |
![]() |
Robustness considerations in selecting efficient two-color microarray designs |
![]() |
Sample size and proportion of Japanese patients in multi-regional trials. |
![]() |
Seventh international French Society of Statistics meeting on statistical methods in biopharmacy: emerging topics for statistical methodology in clinical drug development |
![]() |
A simple and flexible graphical approach for adaptive group-sequential clinical trials |
![]() |
Simultaneous confidence bands for a percentile line in linear regression |
![]() |
Simultaneous inference for several quantiles of a normal population with applications. |
![]() |
Statistical analysis of monotone or non-monotone dose-response data from in vitro toxicological assays |
![]() |
Statistical calibration and exact one-sided simultaneous tolerance intervals for polynomial regression |
![]() |
Symmetric graphs for equally weighted tests, with application to the Hochberg procedure |
![]() |
Test and power considerations for multiple endpoint analyses using sequentially rejective graphical procedures |
![]() |
Trimmed weighted Simes' test for two one-sided hypotheses with arbitrarily correlated test statistics. |
![]() |
Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials. |
![]() |
Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls. |
![]() |
Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim |
![]() |
সংশোধন |
![]() |